What is the latest market reference price of Vigabatrin/vigabatrin?

Vigabatrin/vigabatrin is mainly used to treat epilepsy, especially for some patients with refractory epilepsy that are difficult to control with conventional drugs. It has significant efficacy. Its main indications include:

1. Refractory epilepsy: Vigabatrin can be used as an effective treatment option for epilepsy patients whose conventional anti-epileptic drugs are ineffective. It reduces the occurrence of epileptic seizures by inhibiting excessive excitability of neurons, and is especially suitable for intractable epilepsy in adults and children.

2. Infantile spasms: This is a common type of epilepsy in infants and young children. Vigabatrin has been proven to have a good effect on infantile spasms. It can effectively control epileptic seizures and reduce neurological damage in infants.

3. Partial epileptic seizures: This drug can also be used to control some refractory partial epileptic seizures. For patients with partial epilepsy that cannot be controlled by other drugs, Vigabatrin provides an effective treatment option.

Based on the latest market reference price, the price of Vigabatrin will fluctuate according to differences in different regions and sales channels. Taking the domestic market as an example, the original drug price of 30 bags of Vigabatrin Oral Solution500mg is about RMB 1,000. However, since there are some other country versions of the drug on the market, prices may vary. For example, the price of 500 mg 100 bags of oral solution in Turkey and Hong Kong is about RMB 1,000, while the price of some generic drugs is relatively low, with the price of 500 mg*100 bags being about RMB 900. Prices may fluctuate due to exchange rate fluctuations and changes in market demand, so patients need to confirm the latest drug prices with local pharmacies when purchasing.

Overall, Vigabatrin has high accessibility among domestic patients through the support of medical insurance policies. Especially for some families with heavy financial burdens, Vigabatrin’s medical insurance coverage has greatly reduced the financial pressure on patients.

Reference materials:https://www.sabril.net/